ICAM1 and triple-negative breast carcinoma: This study introduces a novel lipid nanoparticle (LNP) small interfering RNA (siRNA) delivery system targeting intercellular adhesion molecule-1 (ICAM-1) for triple-negative breast cancer (TNBC).